Patrick Deval L
SEC-identified person · CIK 1053466 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Twilio INC TWLO | Director | filed 2021 - 2026 |
| Toast, Inc. TOST | Director | filed 2021 - 2026 |
| Cerevel Therapeutics Holdings, Inc. CERF | Director | filed 2021 - 2024 |
| Greenlight Biosciences Holdings, PBC GRNA | Director | filed 2021 - 2023 |
| American Well Corp AMWL | Director | filed 2020 - 2023 |
| Global Blood Therapeutics, Inc. GBT | Director | filed 2015 - 2022 |
| Springworks Therapeutics, Inc. [SWTX | Director | filed 2019 - 2019 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.